ONTOLOGY REPORT - ANNOTATIONS
| Term: | chromenone |
|
| Accession: | CHEBI:38445
|
browse the term
|
| Synonyms: | related_synonym: | chromenones |
|
|
4-methylumbelliferone
|
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
multiple interactions |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases glucuronidation |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases glucuronidation |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases glucuronidation |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases glucuronidation |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
increases glucuronidation |
ISO |
9 |
87,081,132 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases glucuronidation |
ISO |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
increases glucuronidation |
ISO |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
increases glucuronidation |
ISO |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
increases glucuronidation |
ISO |
9 |
86,986,915 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
increases glucuronidation |
ISO |
9 |
86,986,915 |
87,098,362 |
RGD:6480464 |
CTD |
7-ethoxycoumarin
|
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
coumaphos
|
| G |
Rara |
retinoic acid receptor, alpha |
|
increases activity |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
coumarin
|
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
affects expression |
EXP |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
affects expression |
EXP |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
affects expression |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Acot4 |
acyl-CoA thioesterase 4 |
|
increases expression |
EXP |
6 |
108,075,508 |
108,080,792 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
increases expression |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
decreases expression |
EXP |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
|
affects expression |
EXP |
4 |
64,972,908 |
65,005,896 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
increases expression |
EXP |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Anxa7 |
annexin A7 |
|
increases expression |
EXP |
15 |
4,047,956 |
4,075,981 |
RGD:6480464 |
CTD |
| G |
Apbb3 |
amyloid beta (A4) precursor protein-binding, family B, member 3 |
|
decreases expression |
EXP |
18 |
29,310,421 |
29,317,546 |
RGD:6480464 |
CTD |
| G |
Apcs |
amyloid P component, serum |
|
decreases expression |
EXP |
13 |
89,112,845 |
89,113,641 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects expression |
EXP |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression |
EXP |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Atpif1 |
ATPase inhibitory factor 1 |
|
increases expression |
EXP |
5 |
152,618,307 |
152,622,024 |
RGD:6480464 |
CTD |
| G |
Atrn |
attractin |
|
decreases expression |
EXP |
3 |
118,539,268 |
118,701,177 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
decreases expression |
EXP |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
affects expression |
EXP |
12 |
17,492,913 |
17,498,949 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bbox1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
|
decreases expression |
EXP |
3 |
95,747,735 |
95,786,852 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bhlha15 |
basic helix-loop-helix family, member a15 |
|
increases expression |
EXP |
12 |
10,747,865 |
10,752,041 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
decreases expression |
EXP |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
affects expression |
EXP |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
increases expression |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
increases expression |
EXP |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
EXP |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
increases expression |
EXP |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
EXP |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
affects expression |
EXP |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cisd3 |
CDGSH iron sulfur domain 3 |
|
increases expression |
EXP |
10 |
86,434,901 |
86,437,932 |
RGD:6480464 |
CTD |
| G |
Coq6 |
coenzyme Q6 homolog, monooxygenase (S. cerevisiae) |
|
increases expression |
EXP |
6 |
108,425,610 |
108,436,950 |
RGD:6480464 |
CTD |
| G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
|
increases expression |
EXP |
7 |
127,123,883 |
127,130,729 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
decreases expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Cryl1 |
crystallin, lambda 1 |
|
increases expression |
EXP |
15 |
36,320,075 |
36,440,579 |
RGD:6480464 |
CTD |
| G |
Csad |
cysteine sulfinic acid decarboxylase |
|
decreases expression |
EXP |
7 |
140,917,995 |
140,944,405 |
RGD:6480464 |
CTD |
| G |
Csrp1 |
cysteine and glycine-rich protein 1 |
|
decreases expression |
EXP |
13 |
48,750,202 |
48,775,815 |
RGD:6480464 |
CTD |
| G |
Ctf1 |
cardiotrophin 1 |
|
increases expression |
EXP |
1 |
187,001,445 |
187,006,655 |
RGD:6480464 |
CTD |
| G |
Cth |
cystathionase (cystathionine gamma-lyase) |
|
affects expression |
EXP |
2 |
256,056,562 |
256,082,248 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cyb561 |
cytochrome b-561 |
|
increases expression |
EXP |
10 |
95,328,354 |
95,334,603 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
decreases activity |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
decreases metabolic processing |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases metabolic processing |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
affects metabolic processing |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
affects metabolic processing |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
affects metabolic processing |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases hydroxylation |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases hydroxylation |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases metabolic processing |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases hydroxylation |
EXP |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
affects expression |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
decreases expression |
EXP |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
|
increases expression |
EXP |
2 |
51,881,101 |
51,881,461 |
RGD:6480464 |
CTD |
| G |
Ddost |
dolichyl-diphosphooligosaccharide-protein glycosyltransferase |
|
increases expression |
EXP |
5 |
157,083,337 |
157,090,071 |
RGD:6480464 |
CTD |
| G |
Ddx31 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 |
|
decreases expression |
EXP |
3 |
7,849,554 |
7,914,005 |
RGD:6480464 |
CTD |
| G |
Dnajb11 |
DnaJ (Hsp40) homolog, subfamily B, member 11 |
|
increases expression |
EXP |
11 |
80,360,406 |
80,376,870 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
affects expression |
EXP |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
increases expression |
EXP |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dscc1 |
DNA replication and sister chromatid cohesion 1 |
|
increases expression |
EXP |
7 |
91,602,671 |
91,618,122 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
affects expression |
EXP |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Eef1e1 |
eukaryotic translation elongation factor 1 epsilon 1 |
|
increases expression |
EXP |
17 |
32,217,424 |
32,228,130 |
RGD:6480464 |
CTD |
| G |
Ell3 |
elongation factor RNA polymerase II-like 3 |
|
increases expression |
EXP |
3 |
108,241,165 |
108,245,260 |
RGD:6480464 |
CTD |
| G |
Eme2 |
essential meiotic endonuclease 1 homolog 2 (S. pombe) |
|
increases expression |
EXP |
10 |
14,140,925 |
14,144,052 |
RGD:6480464 |
CTD |
| G |
F9 |
coagulation factor IX |
|
increases response to substance |
ISO |
X |
145,527,978 |
145,575,966 |
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
decreases expression |
EXP |
1 |
212,670,792 |
212,685,718 |
RGD:6480464 |
CTD |
| G |
Fam111a |
family with sequence similarity 111, member A |
|
increases expression |
EXP |
1 |
215,581,410 |
215,597,220 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fen1 |
flap structure-specific endonuclease 1 |
|
increases expression |
EXP |
1 |
212,688,118 |
212,692,486 |
RGD:6480464 |
CTD |
| G |
Fgg |
fibrinogen gamma chain |
|
affects expression |
EXP |
2 |
174,727,312 |
174,734,594 |
RGD:6480464 |
CTD |
| G |
Fggy |
FGGY carbohydrate kinase domain containing |
|
decreases expression |
EXP |
5 |
115,881,466 |
116,286,358 |
RGD:6480464 |
CTD |
| G |
Fkbp11 |
FK506 binding protein 11 |
|
increases expression |
EXP |
7 |
137,490,985 |
137,494,418 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
decreases expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Nrep |
neuronal regeneration related protein |
|
decreases expression |
EXP |
18 |
25,842,127 |
25,868,219 |
RGD:6480464 |
CTD |
| G |
Nrtn |
neurturin |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ntng1 |
netrin G1 |
|
decreases expression |
EXP |
2 |
205,438,061 |
205,806,249 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
increases expression |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Oaf |
OAF homolog (Drosophila) |
|
decreases expression |
EXP |
8 |
46,224,861 |
46,242,832 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
decreases expression |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Ogn |
osteoglycin |
|
decreases expression |
EXP |
17 |
20,987,029 |
21,007,525 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
decreases activity |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
|
increases expression |
EXP |
15 |
33,671,834 |
33,680,613 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
decreases expression |
EXP |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
increases expression |
EXP |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
increases expression |
EXP |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
decreases expression |
EXP |
10 |
83,710,448 |
83,724,973 |
RGD:6480464 |
CTD |
| G |
Pla2g12a |
phospholipase A2, group XIIA |
|
increases expression |
EXP |
2 |
227,331,049 |
227,348,091 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
increases expression |
EXP |
1 |
95,010,719 |
95,021,686 |
RGD:6480464 |
CTD |
| G |
Pold2 |
polymerase (DNA directed), delta 2, accessory subunit |
|
increases expression |
EXP |
14 |
86,535,757 |
86,541,920 |
RGD:6480464 |
CTD |
| G |
Polr1e |
polymerase (RNA) I polypeptide E |
|
increases expression |
EXP |
5 |
61,581,916 |
61,598,266 |
RGD:6480464 |
CTD |
| G |
Ptgr1 |
prostaglandin reductase 1 |
|
increases expression |
EXP |
5 |
77,010,809 |
77,029,326 |
RGD:6480464 |
CTD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
decreases expression |
EXP |
1 |
79,021,831 |
79,059,686 |
RGD:6480464 |
CTD |
| G |
R3hdm1 |
R3H domain containing 1 |
|
increases expression |
EXP |
13 |
40,803,986 |
40,942,005 |
RGD:6480464 |
CTD |
| G |
R3hdm2 |
R3H domain containing 2 |
|
decreases expression |
EXP |
7 |
67,364,886 |
67,475,880 |
RGD:6480464 |
CTD |
| G |
Rab3d |
RAB3D, member RAS oncogene family |
|
increases expression |
EXP |
8 |
21,012,295 |
21,021,327 |
RGD:6480464 |
CTD |
| G |
Rbm3 |
RNA binding motif (RNP1, RRM) protein 3 |
|
increases expression |
EXP |
X |
26,379,303 |
26,382,739 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
decreases expression |
EXP |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
RGD1560171 |
similar to PRO0149 protein |
|
increases expression |
EXP |
X |
146,111,116 |
146,112,319 |
RGD:6480464 |
CTD |
| G |
RGD1564865 |
similar to 20-alpha-hydroxysteroid dehydrogenase |
|
decreases expression |
EXP |
17 |
76,868,408 |
76,903,914 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
decreases expression |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rgs8 |
regulator of G-protein signaling 8 |
|
decreases expression |
EXP |
13 |
68,735,814 |
68,766,956 |
RGD:6480464 |
CTD |
| G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator candidate |
|
decreases expression |
EXP |
3 |
35,590,166 |
35,591,583 |
RGD:6480464 |
CTD |
| G |
RT1-Ba |
RT1 class II, locus Ba |
|
increases expression |
EXP |
20 |
4,697,971 |
4,702,564 |
RGD:6480464 |
CTD |
| G |
RT1-EC2 |
RT1 class Ib, locus EC2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Sdf2l1 |
stromal cell-derived factor 2-like 1 |
|
increases expression |
EXP |
11 |
85,878,093 |
85,880,335 |
RGD:6480464 |
CTD |
| G |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
|
increases expression |
EXP |
6 |
115,431,169 |
115,472,901 |
RGD:6480464 |
CTD |
| G |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
|
increases expression |
EXP |
3 |
111,890,235 |
111,948,388 |
RGD:6480464 |
CTD |
| G |
Slc17a3 |
solute carrier family 17 (sodium phosphate), member 3 |
|
increases expression |
EXP |
17 |
48,599,049 |
48,620,786 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
affects expression |
EXP |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc28a2 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 |
|
decreases expression |
EXP |
3 |
109,350,531 |
109,372,027 |
RGD:6480464 |
CTD |
| G |
Slc35e3 |
solute carrier family 35, member E3 |
|
increases expression |
EXP |
7 |
57,043,097 |
57,056,156 |
RGD:6480464 |
CTD |
| G |
Slc6a13 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 13 |
|
decreases expression |
EXP |
4 |
157,736,264 |
157,771,945 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
increases expression |
EXP |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Smpdl3b |
sphingomyelin phosphodiesterase, acid-like 3B |
|
increases expression |
EXP |
5 |
152,390,454 |
152,415,338 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
increases expression |
EXP |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Sult1b1 |
sulfotransferase family, cytosolic, 1B, member 1 |
|
affects expression |
EXP |
14 |
22,019,193 |
22,031,914 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
decreases expression |
EXP |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
decreases expression |
EXP |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sycp3 |
synaptonemal complex protein 3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Syne4 |
spectrin repeat containing, nuclear envelope family member 4 |
|
increases expression |
EXP |
1 |
85,261,148 |
85,265,361 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
increases expression |
EXP |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
affects expression |
EXP |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
decreases expression |
EXP |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Tmed3 |
transmembrane emp24 protein transport domain containing 3 |
|
increases expression |
EXP |
8 |
94,590,177 |
94,598,090 |
RGD:6480464 |
CTD |
| G |
Tmem66 |
transmembrane protein 66 |
|
increases expression |
EXP |
16 |
61,744,563 |
61,762,812 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
|
decreases expression |
EXP |
5 |
168,071,159 |
168,099,501 |
RGD:6480464 |
CTD |
| G |
Trpc2 |
transient receptor potential cation channel, subfamily C, member 2 |
|
increases expression |
EXP |
1 |
159,542,801 |
159,576,294 |
RGD:6480464 |
CTD |
| G |
Tst |
thiosulfate sulfurtransferase |
|
affects expression |
EXP |
7 |
116,349,579 |
116,355,921 |
RGD:6480464 |
CTD |
| G |
Ttc39a |
tetratricopeptide repeat domain 39A |
|
increases expression |
EXP |
5 |
130,761,328 |
130,800,627 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
EXP |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
increases expression |
EXP |
14 |
45,542,781 |
45,570,961 |
RGD:6480464 |
CTD |
| G |
Ugt2b |
UDP glycosyltransferase 2 family, polypeptide B |
|
decreases expression |
EXP |
14 |
22,154,370 |
22,178,222 |
RGD:6480464 |
CTD |
| G |
Ust5r |
integral membrane transport protein UST5r |
|
decreases expression |
EXP |
1 |
210,760,433 |
210,838,520 |
RGD:6480464 |
CTD |
| G |
Vkorc1 |
vitamin K epoxide reductase complex, subunit 1 |
|
decreases response to substance |
ISO |
1 |
187,176,745 |
187,179,266 |
RGD:6480464 |
CTD |
| G |
Vkorc1 |
vitamin K epoxide reductase complex, subunit 1 |
|
increases response to substance |
ISO |
1 |
187,176,745 |
187,179,266 |
RGD:6480464 |
CTD |
| G |
Vkorc1 |
vitamin K epoxide reductase complex, subunit 1 |
|
increases response to substance |
ISO |
1 |
187,176,745 |
187,179,266 |
RGD:6480464 |
CTD |
| G |
Wee1 |
wee 1 homolog (S. pombe) |
|
increases expression |
EXP |
1 |
167,769,797 |
167,788,199 |
RGD:6480464 |
CTD |
| G |
Yrdc |
yrdC domain containing (E.coli) |
|
increases expression |
EXP |
5 |
144,183,573 |
144,188,418 |
RGD:6480464 |
CTD |
| G |
Zfp444 |
zinc finger protein 444 |
|
increases expression |
EXP |
1 |
66,145,324 |
66,162,706 |
RGD:6480464 |
CTD |
| G |
Zfp593 |
zinc finger protein 593 |
|
increases expression |
EXP |
5 |
152,987,725 |
152,990,053 |
RGD:6480464 |
CTD |
LY294002
|
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
multiple interactions |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
decreases expression |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Acvr2b |
activin A receptor, type IIB |
|
multiple interactions |
ISO |
8 |
124,364,330 |
124,395,748 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
multiple interactions |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
multiple interactions |
EXP |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases activity |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases activity |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases activity |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases activity |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1s1 |
AKT1 substrate 1 (proline-rich) |
|
decreases phosphorylation |
EXP |
1 |
95,325,272 |
95,328,510 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
multiple interactions |
ISO |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Apln |
apelin |
|
increases expression |
ISO |
X |
134,387,285 |
134,396,762 |
RGD:6480464 |
CTD |
| G |
Apln |
apelin |
|
increases secretion |
ISO |
X |
134,387,285 |
134,396,762 |
RGD:6480464 |
CTD |
| G |
Apln |
apelin |
|
multiple interactions |
ISO |
X |
134,387,285 |
134,396,762 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
multiple interactions |
ISO |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
decreases expression |
ISO |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases phosphorylation |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases phosphorylation |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases phosphorylation |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects localization |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases phosphorylation |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
multiple interactions |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases degradation |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
multiple interactions |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
multiple interactions |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
decreases expression |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
decreases expression |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
multiple interactions |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
decreases expression |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
decreases expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
decreases expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Btc |
betacellulin |
|
multiple interactions |
EXP |
14 |
18,194,470 |
18,235,228 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Car9 |
carbonic anhydrase 9 |
|
multiple interactions |
ISO |
5 |
59,986,413 |
59,993,015 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
multiple interactions |
EXP |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
multiple interactions |
EXP |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
multiple interactions |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
multiple interactions |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl9 |
chemokine (C-C motif) ligand 9 |
|
multiple interactions |
ISO |
10 |
71,645,931 |
71,650,814 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
multiple interactions |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
increases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases methylation |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
multiple interactions |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cdk16 |
cyclin-dependent kinase 16 |
|
multiple interactions |
ISO |
X |
12,910,972 |
12,916,939 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
multiple interactions |
EXP |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
decreases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
decreases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
decreases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
multiple interactions |
ISO |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions |
ISO |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Cldn2 |
claudin 2 |
|
multiple interactions |
EXP |
X |
127,538,685 |
127,549,019 |
RGD:6480464 |
CTD |
| G |
Cldn5 |
claudin 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Ctf1 |
cardiotrophin 1 |
|
multiple interactions |
ISO |
1 |
187,001,445 |
187,006,655 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
multiple interactions |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Dag1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
multiple interactions |
ISO |
8 |
113,470,871 |
113,483,433 |
RGD:6480464 |
CTD |
| G |
Dct |
dopachrome tautomerase |
|
multiple interactions |
ISO |
15 |
102,798,699 |
102,832,240 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
multiple interactions |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
decreases expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Dgkd |
diacylglycerol kinase, delta |
|
multiple interactions |
ISO |
9 |
86,836,919 |
86,895,274 |
RGD:6480464 |
CTD |
| G |
Dpp3 |
dipeptidylpeptidase 3 |
|
multiple interactions |
ISO |
3 |
138,286,277 |
138,288,887 |
RGD:6480464 |
CTD |
| G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
|
multiple interactions |
ISO |
6 |
135,318,083 |
135,391,459 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
multiple interactions |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
|
decreases expression |
ISO |
3 |
170,295,327 |
170,304,505 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Eif4b |
eukaryotic translation initiation factor 4B |
|
multiple interactions |
ISO |
7 |
140,814,663 |
140,836,485 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
multiple interactions |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
decreases phosphorylation |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
decreases phosphorylation |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma, 1 |
|
multiple interactions |
ISO |
11 |
82,451,555 |
82,471,735 |
RGD:6480464 |
CTD |
| G |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
|
increases expression |
ISO |
1 |
168,829,099 |
168,841,605 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
multiple interactions |
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
multiple interactions |
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
multiple interactions |
ISO |
7 |
1,858,057 |
1,877,353 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Ets1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
multiple interactions |
ISO |
8 |
32,481,694 |
32,545,237 |
RGD:6480464 |
CTD |
| G |
F11r |
F11 receptor |
|
multiple interactions |
ISO |
13 |
87,369,918 |
87,393,508 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
multiple interactions |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
multiple interactions |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
multiple interactions |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fam168a |
family with sequence similarity 168, member A |
|
multiple interactions |
ISO |
1 |
158,140,473 |
158,287,606 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
decreases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
decreases expression |
ISO |
7 |
94,909,568 |
94,942,444 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
multiple interactions |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
decreases activity |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
multiple interactions |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
multiple interactions |
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
multiple interactions |
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
decreases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
EXP |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
multiple interactions |
ISO |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
multiple interactions |
EXP |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
multiple interactions |
ISO |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
Gabpa |
GA binding protein transcription factor, alpha subunit |
|
multiple interactions |
EXP |
11 |
24,323,963 |
24,352,754 |
RGD:6480464 |
CTD |
| G |
Gbp1 |
guanylate binding protein 1, interferon-inducible |
|
multiple interactions |
ISO |
2 |
240,715,506 |
240,739,741 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
decreases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
decreases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
decreases activity |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
multiple interactions |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
multiple interactions |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
multiple interactions |
EXP |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
multiple interactions |
EXP |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
decreases phosphorylation |
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
multiple interactions |
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
decreases phosphorylation |
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
multiple interactions |
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases response to substance |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
affects response to substance |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
multiple interactions |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
decreases expression |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
multiple interactions |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
decreases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
multiple interactions |
ISO |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases activity |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
multiple interactions |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf1a |
HNF1 homeobox A |
|
multiple interactions |
EXP |
12 |
42,919,574 |
42,945,670 |
RGD:6480464 |
CTD |
| G |
Hnf1b |
HNF1 homeobox B |
|
decreases expression |
ISO |
10 |
72,081,091 |
72,187,014 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
multiple interactions |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
multiple interactions |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
multiple interactions |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspb8 |
heat shock protein B8 |
|
decreases expression |
ISO |
12 |
41,407,166 |
41,421,565 |
RGD:6480464 |
CTD |
| G |
Iapp |
islet amyloid polypeptide |
|
multiple interactions |
ISO |
4 |
179,855,956 |
179,860,871 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
multiple interactions |
ISO |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
multiple interactions |
ISO |
7 |
142,254,256 |
142,277,464 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgav |
integrin, alpha V |
|
multiple interactions |
ISO |
3 |
66,953,403 |
67,029,774 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
multiple interactions |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
EXP |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases secretion |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases secretion |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
multiple interactions |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
decreases response to substance |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lipa |
lipase A, lysosomal acid, cholesterol esterase |
|
multiple interactions |
ISO |
1 |
238,466,493 |
238,500,195 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
M6pr |
mannose-6-phosphate receptor, cation dependent |
|
multiple interactions |
ISO |
4 |
158,727,542 |
158,736,681 |
RGD:6480464 |
CTD |
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
decreases activity |
ISO |
18 |
61,708,388 |
61,760,004 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
|
multiple interactions |
ISO |
10 |
47,075,270 |
47,096,617 |
RGD:6480464 |
CTD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
multiple interactions |
ISO |
2 |
43,062,252 |
43,126,058 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
multiple interactions |
ISO |
14 |
7,719,595 |
8,010,694 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
increases degradation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mitf |
microphthalmia-associated transcription factor |
|
multiple interactions |
ISO |
4 |
132,534,187 |
132,745,669 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases activity |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases activity |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases activity |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
multiple interactions |
ISO |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
multiple interactions |
ISO |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
decreases expression |
ISO |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
decreases activity |
ISO |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
decreases expression |
ISO |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases activity |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases activity |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases activity |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases activity |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
decreases response to substance |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases phosphorylation |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
multiple interactions |
ISO |
17 |
68,782,708 |
68,867,101 |
RGD:6480464 |
CTD |
| G |
Mycn |
v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) |
|
multiple interactions |
ISO |
6 |
36,508,262 |
36,514,071 |
RGD:6480464 |
CTD |
| G |
Myh4 |
myosin, heavy chain 4, skeletal muscle |
|
multiple interactions |
ISO |
10 |
53,931,880 |
53,955,029 |
RGD:6480464 |
CTD |
| G |
Napa |
N-ethylmaleimide-sensitive factor attachment protein, alpha |
|
multiple interactions |
ISO |
1 |
76,438,616 |
76,457,225 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases activity |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
decreases activity |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases activity |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
multiple interactions |
ISO |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Nox1 |
NADPH oxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
multiple interactions |
ISO |
5 |
64,713,468 |
64,753,311 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
multiple interactions |
EXP |
4 |
56,949,553 |
57,048,149 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
multiple interactions |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
multiple interactions |
ISO |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
decreases transport |
ISO |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Ntf4 |
neurotrophin 4 |
|
decreases transport |
ISO |
1 |
95,885,577 |
95,888,408 |
RGD:6480464 |
CTD |
| G |
Nts |
neurotensin |
|
multiple interactions |
ISO |
7 |
40,474,654 |
40,484,058 |
RGD:6480464 |
CTD |
| G |
Nup153 |
nucleoporin 153 |
|
affects localization |
ISO |
17 |
24,031,666 |
24,084,210 |
RGD:6480464 |
CTD |
| G |
Nup153 |
nucleoporin 153 |
|
multiple interactions |
ISO |
17 |
24,031,666 |
24,084,210 |
RGD:6480464 |
CTD |
| G |
Nup88 |
nucleoporin 88 |
|
affects localization |
ISO |
10 |
57,849,428 |
57,874,078 |
RGD:6480464 |
CTD |
| G |
Nup88 |
nucleoporin 88 |
|
multiple interactions |
ISO |
10 |
57,849,428 |
57,874,078 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
multiple interactions |
EXP |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
multiple interactions |
EXP |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pdcd4 |
programmed cell death 4 |
|
increases expression |
ISO |
1 |
260,183,648 |
260,202,032 |
RGD:6480464 |
CTD |
| G |
Pdcd4 |
programmed cell death 4 |
|
multiple interactions |
ISO |
1 |
260,183,648 |
260,202,032 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
multiple interactions |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
multiple interactions |
ISO |
3 |
54,292,076 |
54,319,242 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
decreases activity |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
|
decreases activity |
ISO |
8 |
103,886,682 |
103,957,112 |
RGD:6480464 |
CTD |
| G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
decreases activity |
ISO |
5 |
166,735,274 |
166,761,189 |
RGD:6480464 |
CTD |
| G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
multiple interactions |
ISO |
6 |
50,441,892 |
50,476,931 |
RGD:6480464 |
CTD |
| G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
decreases activity |
ISO |
6 |
50,441,892 |
50,476,931 |
RGD:6480464 |
CTD |
| G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
multiple interactions |
ISO |
6 |
50,441,892 |
50,476,931 |
RGD:6480464 |
CTD |
| G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
decreases activity |
ISO |
6 |
50,441,892 |
50,476,931 |
RGD:6480464 |
CTD |
| G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
decreases expression |
ISO |
8 |
19,669,537 |
19,681,741 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
multiple interactions |
EXP |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
multiple interactions |
EXP |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
multiple interactions |
EXP |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppif |
peptidylprolyl isomerase F |
|
multiple interactions |
ISO |
16 |
1,292,835 |
1,299,556 |
RGD:6480464 |
CTD |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
multiple interactions |
ISO |
10 |
87,121,889 |
87,131,587 |
RGD:6480464 |
CTD |
| G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
|
multiple interactions |
ISO |
18 |
35,865,837 |
36,318,308 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
affects localization |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
decreases phosphorylation |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcz |
protein kinase C, zeta |
|
decreases phosphorylation |
ISO |
5 |
172,061,825 |
172,172,793 |
RGD:6480464 |
CTD |
| G |
Prkcz |
protein kinase C, zeta |
|
affects localization |
ISO |
5 |
172,061,825 |
172,172,793 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
multiple interactions |
ISO |
7 |
110,933,298 |
111,084,554 |
RGD:6480464 |
CTD |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
multiple interactions |
ISO |
3 |
159,070,473 |
159,116,792 |
RGD:6480464 |
CTD |
| G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
multiple interactions |
ISO |
12 |
36,501,886 |
36,558,055 |
RGD:6480464 |
CTD |
| G |
Rab32 |
RAB32, member RAS oncogene family |
|
multiple interactions |
ISO |
1 |
5,203,908 |
5,218,416 |
RGD:6480464 |
CTD |
| G |
Rad23b |
RAD23 homolog B (S. cerevisiae) |
|
multiple interactions |
ISO |
5 |
73,256,542 |
73,294,296 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
multiple interactions |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbl1 |
retinoblastoma-like 1 (p107) |
|
decreases expression |
ISO |
3 |
147,734,622 |
147,796,630 |
RGD:6480464 |
CTD |
| G |
Rel |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
14 |
104,645,370 |
104,671,275 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
decreases phosphorylation |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
multiple interactions |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
decreases phosphorylation |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
multiple interactions |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
decreases phosphorylation |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
decreases phosphorylation |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
multiple interactions |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
multiple interactions |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
multiple interactions |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
multiple interactions |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
decreases phosphorylation |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
decreases phosphorylation |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Scarb2 |
scavenger receptor class B, member 2 |
|
multiple interactions |
ISO |
14 |
17,119,366 |
17,170,850 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
multiple interactions |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Sec23a |
Sec23 homolog A (S. cerevisiae) |
|
multiple interactions |
ISO |
6 |
79,660,575 |
79,706,898 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
decreases expression |
ISO |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sirpa |
signal-regulatory protein alpha |
|
multiple interactions |
ISO |
3 |
117,210,116 |
117,247,840 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
multiple interactions |
EXP |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
multiple interactions |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
multiple interactions |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
multiple interactions |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
increases phosphorylation |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
multiple interactions |
ISO |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
multiple interactions |
ISO |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Sts |
steroid sulfatase (microsomal), isozyme S |
|
multiple interactions |
ISO |
X |
63,915,803 |
63,923,834 |
RGD:6480464 |
CTD |
| G |
Stx7 |
syntaxin 7 |
|
multiple interactions |
ISO |
1 |
21,721,897 |
21,762,024 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
multiple interactions |
ISO |
1 |
30,445,180 |
30,465,942 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
multiple interactions |
EXP |
1 |
30,445,180 |
30,465,942 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
decreases activity |
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tfam |
transcription factor A, mitochondrial |
|
multiple interactions |
EXP |
20 |
18,100,629 |
18,112,682 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases response to substance |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
multiple interactions |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
multiple interactions |
ISO |
3 |
137,158,955 |
137,162,607 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trim63 |
tripartite motif containing 63, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
5 |
153,059,573 |
153,073,907 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Ttn |
titin |
|
multiple interactions |
EXP |
3 |
59,404,023 |
59,665,308 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
multiple interactions |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
multiple interactions |
ISO |
1 |
143,641,257 |
143,746,315 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
multiple interactions |
ISO |
5 |
99,518,306 |
99,537,289 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
multiple interactions |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases activity |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
novobiocin
|
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
EXP |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
increases expression |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
decreases expression |
ISO |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
Term paths to the root
|